VALPROATE-AFT sodium valproate 300 mg/3 ml solution for intravenous infusion or injection vials Австралія - англійська - Department of Health (Therapeutic Goods Administration)

valproate-aft sodium valproate 300 mg/3 ml solution for intravenous infusion or injection vials

aft pharmaceuticals pty ltd - sodium valproate, quantity: 100 mg/ml - injection, intravenous infusion - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic potassium phosphate; water for injections; nitrogen - valproate-aft is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible

VALPROATE-AFT sodium valproate 400 mg/4 ml solution for intravenous infusion or injection ampoules Австралія - англійська - Department of Health (Therapeutic Goods Administration)

valproate-aft sodium valproate 400 mg/4 ml solution for intravenous infusion or injection ampoules

aft pharmaceuticals pty ltd - sodium valproate, quantity: 100 mg/ml - injection, intravenous infusion - excipient ingredients: monobasic potassium phosphate; dibasic sodium phosphate dodecahydrate; water for injections; nitrogen - valproate-aft is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

VALPROATE-AFT sodium valproate 1000 mg/10 ml solution for intravenous infusion or injection ampoules Австралія - англійська - Department of Health (Therapeutic Goods Administration)

valproate-aft sodium valproate 1000 mg/10 ml solution for intravenous infusion or injection ampoules

aft pharmaceuticals pty ltd - sodium valproate, quantity: 100 mg/ml - injection, intravenous infusion - excipient ingredients: dibasic sodium phosphate dodecahydrate; nitrogen; water for injections; monobasic potassium phosphate - valproate-aft is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

VALPROATE-AFT sodium valproate 400 mg/4 ml solution for intravenous infusion or injection vials Австралія - англійська - Department of Health (Therapeutic Goods Administration)

valproate-aft sodium valproate 400 mg/4 ml solution for intravenous infusion or injection vials

aft pharmaceuticals pty ltd - sodium valproate, quantity: 100 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections; monobasic potassium phosphate; dibasic sodium phosphate dodecahydrate; nitrogen - valproate-aft is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible

VALPROATE-AFT sodium valproate 300 mg/3 ml solution for intravenous infusion or injection ampoules Австралія - англійська - Department of Health (Therapeutic Goods Administration)

valproate-aft sodium valproate 300 mg/3 ml solution for intravenous infusion or injection ampoules

aft pharmaceuticals pty ltd - sodium valproate, quantity: 100 mg/ml - injection, intravenous infusion - excipient ingredients: nitrogen; dibasic sodium phosphate dodecahydrate; monobasic potassium phosphate; water for injections - valproate-aft is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

VALPROATE-AFT sodium valproate 1000 mg/10 ml solution for intravenous infusion or injection vial Австралія - англійська - Department of Health (Therapeutic Goods Administration)

valproate-aft sodium valproate 1000 mg/10 ml solution for intravenous infusion or injection vial

aft pharmaceuticals pty ltd - sodium valproate, quantity: 100 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections; nitrogen; monobasic potassium phosphate; dibasic sodium phosphate dodecahydrate - valproate-aft is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible

Sodium Valproate 100mg/ml Solution for Injection or Infusion (4ml) Мальта - англійська - Medicines Authority

sodium valproate 100mg/ml solution for injection or infusion (4ml)

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - valproate sodium - solution for infusion or injection - valproate sodium 100 mg/ml - antiepileptics

Jetrea 0.5mg0.2ml concentrate for solution for injection vials Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

jetrea 0.5mg0.2ml concentrate for solution for injection vials

alcon eye care ltd - ocriplasmin - solution for injection - 2.5mg/1ml

DEPALEPT ORAL SOLUTION Ізраїль - англійська - Ministry of Health

depalept oral solution

cts chemical industries ltd, israel - valproic acid as sodium - solution (oral) - valproic acid as sodium 200 mg/ml - valproic acid - treatment of generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.

Luminity 225microlitres1.5ml solution for dispersion for injection vials Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

luminity 225microlitres1.5ml solution for dispersion for injection vials

lantheus mi uk ltd - perflutren-containing lipid microspheres - solution for dispersion for injection - 150microlitre/1ml